Wednesday, February 10, 2010, 8:08pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Acorda Therapeutics, Inc. (ACOR)

At 5:00AM SGT: 29.99 USD   0.00 (0.00%)  
 MORE ON ACOR 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Acorda Therapeutics, Inc. (NGM:ACOR) Delayed quote dataEdit
Last Trade:29.99 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:29.99
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:30.00
Day's Range:N/A - N/A
52wk Range:15.52 - 31.78
Volume:0
Avg Vol (3m):785,676
Market Cap:1.14B
P/E (ttm):N/A
EPS (ttm):-2.17
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add ACOR to Portfolio   Download Data

 HEADLINES 
•Cramer's Lighting Round - Dole Is in the Hole (2/9/10)
at Seeking Alpha (Wed 7:29pm)
•Lightning Round: Acodra Therapeutics, Dole Food, Valmont Industries and More
at CNBC (Wed 10:24am)
•'Mad Money Lightning Round': Rambus Heading Higher
at TheStreet.com (Wed 8:35am)
•Cramer's 'Mad Money' Recap: The Catalysts Behind the Rally (Final)
at TheStreet.com (Wed 8:26am)
•[video] Acorda Therapeutics CEO on Drug Pricing
at CNBC (Tue 2:15am)
•4 Winning Biotechs For Your Portfolio: Senior Analyst
at CNBC (Mon, Feb 8)
•Is Biotech Back?
CNBC (Mon, Feb 8)
•[video] Is Biotech Back?
at CNBC (Mon, Feb 8)
•Wild Weekly Wrap-Up: Everyone Just Relax
at Seeking Alpha (Mon, Feb 8)
•Acorda Therapeutics downgraded by Robert W. Baird
Briefing.com (Thu, Feb 4)
•Acorda's Lucky Number 13
at CNBC (Thu, Feb 4)
•Acorda Therapeutics to Present at the 12th Annual BIO CEO & Investor Conference
Business Wire (Wed, Feb 3)
•ACORDA THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Wed, Feb 3)
•Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA (dalfampridine)
Business Wire (Wed, Feb 3)
More Headlines for ACOR...
 ANALYST 
EPS Est (next year) (Dec-09) :-2.22
EPS Est (in 2 years) (Dec-10) :-1.68
Avg Rec (current)*:1.9
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Acorda Therapeutics, Inc., a biopharmaceutical company, engages in the identification, development, and commercialization of various therapies for the improvement of neurological functions in people with multiple sclerosis (MS), spinal cord injury...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices